Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial
暂无分享，去创建一个
A. Tewari | M. Saha | R. Pandey | A. Lahiri | P. Singh | S. Chatterjee | R. Maurya | M. Kumar | S. Paul | A. Kanakan | R. Pandey | A. Roy | A. Mondal | J. Sarif | D. Ganguly | Moumita Saha | P. Bhattacharya | Y. Ray | S. Sengupta | K. Chaudhury | B. Saha | P. Bandopadhyay | R. D’Rozario | S. R. Paul | R. Roy | R. Maiti | S. Bagchi | A. Maiti | M. Perwez | B. Sarkar | J. Vasudevan | Sachin Sharma | D. Biswas | C. Maiti | S. Sengupta | D. Bhowmik | S. Chakraborty | Praveen Singh | Debaleena Bhowmik | S. Paul | B. Sharma Sarkar | S. Mandal | A. Haldar | A. Haldar | S. Sharma | Manish Kumar | Kausik Chaudhury | Rajsekhar Maiti | Md. Masoom Perwez | S. Mandal | S. Sharma | Abhinandan Mondal | A. Tewari | Bibhuti Saha